ThirdAge Metformin and Dapagliflozin Sustain Blood Sugar Levels, Weight Loss ThirdAge The diabetes drug Metformin, in combination with the investigational compound Dapagliflozin, sustained blood sugar levels and weight loss in type 2 diabetes patients, according to a recent study. AstraZeneca and Bristol-Myers Squibb reported the …

Continue reading here:
Metformin and Dapagliflozin Sustain Blood Sugar Levels, Weight Loss – ThirdAge